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 Objective(s):	 Involvement	of	 tyrosinase	 in	 the	 synthesis	of	melanin	and	cell	 signaling	pathway	
has	made	it	an	attractive	target	in	the	search	for	therapeutic	inhibitors	for	treatment	of	different	
skin	hyperpigmentation	disorders	and	melanoma	cancers.		
Materials and Methods:	In	the	present	study,	we	conducted	a	comprehensive	kinetic	analysis	to	
understand	 the	mechanisms	of	 inhibition	 imposed	 by	 2-amino	 benzoic	 acid,	 4-amino	 benzoic	
acid,	 nicotinic	acid,	 and	picolinic	acid	on	 the	monophenolase	and	diphenolase	activities	 of	 the	
mushroom	 tyrosinase,	 and	 then	 MTT	 assay	 was	 exploited	 to	 evaluate	 their	 toxicity	 on	 the	
melanoma	cells.	
Results:	Kinetic	analysis	 revealed	that	nicotinic	acid	and	picolinic	acid	competitively	restricted	
the	 monophenolase	 activity	 with	 inhibition	 constants	 (Ki)	 of	 1.21	 mM	 and	 1.97	mM	 and	 the	
diphenolase	activity	with	Kis	of	2.4	mM	and	2.93	mM,	respectively.	2-aminobenzoic	acid	and	4-
aminobenzoic	acid	inhibited	the	monophenolase	activity	in	a	non-competitive	fashion	with	Kis	of	
5.15	µM	and	3.8	µM	and	the	diphenolase	activity	with	Kis	of	4.72	µM	and	20	µM,	respectively.
Conclusion:	Our	cell-based	data	revealed	that	only	the	pyridine	derivatives	imposed	cytotoxicity	
in	melanoma	cells.	Importantly,	the	concentrations	of	the	inhibitors	leading	to	50%	decrease	in	
the	 cell	 density	 (IC50)	 were	 comparable	 to	 those	 causing	 50%	 drop	 in	 the	 enzyme	 activity,	
implying	 that	 the	 observed	 cytotoxicity	 is	 highly	 likely	 due	 to	 the	 tyrosinase	 inhibition.	
Moreover,	our	cell-based	data	exhibited	that	the	pyridine	derivatives	acted	as	anti-proliferative	
agents,	perhaps	inducing	cytotoxicity	in	the	melanoma	cells	through	inhibition	of	the	tyrosinase	
activities.	
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Introduction	
Tyrosinase	 (EC	1.14.18.1)	 is	 a	 copper-containing	
bifunctional	enzyme,	widely	distributed	in	mammals,	
plants	 and	 micro-organisms	 (1).	 This	 enzyme	
catalyzes	 hydroxylation	 and	 oxidation	 of	 mono-
phenols	 and	 diphenols,	 respectively	 (2).	 In	 fact,	 it	
catalyzes	 the	hydroxylation	 of	 tyrosine	 to	 form	3,4-
dihydroxyphenylalanine	 (L-DOPA),	 and	 L-DOPA	 to	
DOPA	 quinine	 (3).	 Quinones,	 in	 turn,	 develop	
chemically	 to	 melanins	 and	 other	 polyphenolic	
compounds	(4).		
Engagement	 of	 tyrosinase	 in	 important	 cell	
signaling	 pathways	 has	 made	 the	 enzyme	 an	
attractive	 target	 in	 the	 search	 for	 therapeutic	
inhibitors	 for	 prevention	 and	 treatment	 of	 different	
disorders	 including	 skin	 hyperpigmentation	 and	
cancers	 (5,	 6).	 In	 addition,	 inhibition	 of	 tyrosinase	
with	 various	 kinds	 of	 inhibitors	 has	 been	 a	 useful	
tool	 for	 gaining	 better	 understanding	 of	 the	
mechanism	of	action	of	the	enzyme	(7,	8).	In	the	past	
decade,	 a	 large	 number	 of	 compounds	 such	 as	
benzaldehyde	 and	 benzoate	 derivatives	 have	 been	
identified	 that	 inhibit	 the	 enzyme	activity	 (9 16).	 It	
is	 known	 that	 the	 aldehyde	 group	 in	 the	
benzaldehyde	 derivatives	 react	 with	 functional	
groups	 including	 hydroxyl,	 amino	 and	 sulfhydryl	
group	 (9,	 10).	 Previous	 studies	 have	 indicated	 that	
benzaldehyde	 inhibitors	restrict	 the	enzyme	activity	
by	forming	a	Schiff	base	with	a	primary	amino	group	
in	 the	 enzyme	 structure	 (14,	 15).	 It	 has	 also	 been	
suggested	 that	 benzoate	 inhibits	 tyrosinase	 by	 a	
copper	 chelating	mechanism	 (16).	 It	 is	 thought	 that	
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